Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vita Coco Company's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vita Coco Company's regulatory disclosures and financial reporting.
COCO filing discloses resale activity and a restricted stock vesting. The record shows a restricted stock vesting of 2,000 shares on 11/27/2024 issued as compensation. It also lists two resale transactions by Charles Van Es: 2,000 shares sold for $115,960 on 03/16/2026 and 2,000 shares sold for $97,340 on 04/01/2026.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire a total of 45,544 shares of common stock at an exercise price of $10.178 per share, then sold the same 45,544 shares in open-market transactions on two days at weighted average prices of $51.13 and $59.348 per share.
The filing states that these sales were effected under a Rule 10b5-1 trading plan. Following the transactions, Roper directly holds 298,484 shares of common stock. The filing also lists indirect holdings in shares held by his spouse and several Exempt Family Trusts, as well as multiple remaining non-qualified stock option awards with exercise prices ranging from $10.178 to $32.78 and expirations extending to 2035.
COCO affiliate filed a Form 144 proposing sale of 20,000 shares of Common Stock. The filing lists a 20,000-share sale dated 04/30/2026 tied to an option granted 02/10/2020. The record also shows insider sales by Jonathan Burth of 60,000 and 40,000 shares on 03/16/2026 and 04/29/2026, respectively.
The issuer COCO filed a Form 144 notice reporting proposed and recent sales of Common Stock by affiliated holders and a trust. The filing lists a 50,000-share block associated with Fidelity Brokerage Services and two reported sales by the Michael Kirban Revocable Trust of 9,796 shares on 03/11/2026 and 40,204 shares on 03/12/2026.
COCO reported a Rule 144 notice showing 40,000 shares of Common Stock to be sold by Fidelity Brokerage Services LLC on 04/29/2026 for $2,550,000. The filing also records that Jonathan Burth sold 60,000 shares on 03/16/2026 for $3,519,200. The sale is linked to an option granted on 02/10/2020 and the planned sale method is cash.
COCO affiliate reports proposed sale of Common Stock under Form 144. The filing lists multiple proposed or completed dispositions by Martin F. Roper, including repeated blocks of 25,000 shares on several dates in April 2026 and a single 4,456-share sale on 04/13/2026. Transaction prices shown include $1,250,000.00 and similar proceeds for the 25,000-share blocks.
The Vita Coco Company delivered strong Q1 2026 growth and profitability. Net sales rose to $179.8 million, up 37.3% year over year, driven mainly by higher Vita Coco coconut water volumes in both the Americas and International segments.
Gross profit increased to $71.8 million, with gross margin expanding to 39.9% as improved pricing and lower ocean freight more than offset higher finished goods, logistics costs, and legacy tariffs. Net income grew to $30.5 million, with diluted EPS of $0.50, up from $0.31.
Cash and cash equivalents reached $201.9 million with no borrowings on the $60 million Credit Facility, while operating cash flow improved to $15.6 million. The company repurchased 225,273 shares for $11.5 million in Q1 and a further 173,618 shares after quarter-end, and continues to face tariff uncertainty and customer and supplier concentration risks.
The Vita Coco Company reported a strong first quarter of 2026, combining rapid growth with higher profitability and a guidance increase for the full year. Net sales reached $179.8 million, up 37% from $130.9 million, driven by 42% growth in Vita Coco Coconut Water and double‑digit gains in private label and other products. Gross profit rose to $71.8 million, lifting gross margin to about 40% from 36.7% as higher pricing and lower ocean freight more than offset higher inventory and logistics costs.
Net income increased to $30.5 million, or $0.50 per diluted share, compared with $0.31, while non‑GAAP Adjusted EBITDA grew to $38.7 million from $22.5 million. The company ended the quarter with $201.9 million in cash and no debt, after repurchasing $12 million of stock in the quarter and $20 million year‑to‑date through April 28, leaving $21 million authorized under its buyback program. For 2026, Vita Coco now expects net sales between $720 million and $735 million and Adjusted EBITDA between $132 million and $138 million, both higher than its prior outlook, supported by continued brand strength and improved private label trends.
Vita Coco Company, Inc. Chief Executive Officer Martin Roper reported a series of option exercises and share sales in company stock. On April 24 and April 27, he exercised stock options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share and sold 50,000 shares of common stock in open-market transactions at $50.00 per share. Following these transactions, he directly holds 298,484 shares of common stock, with additional indirect holdings reported by his spouse and several Exempt Family Trusts. The filing notes that the sales under these transactions were effected pursuant to a Rule 10b5-1 trading plan, indicating they were pre-scheduled under a pre-arranged trading program.
Company: COCO. This Form 144 notifies proposed sales of common stock by Martin F. Roper and a brokerage holder. The excerpt lists multiple sale dates in April 2026, including repeated 25,000-share transactions and one 4,456-share transaction, with reported proceeds per line. The sales are reported as cash transactions and an option-derived sale appears dated 09/19/2019 (granted).